EUVIMEDEUVIMED entdecken
Crossref

Abstract TH173: Targeting the Endothelin System With a Gut Microbiota-Derived Metabolite in Obesity-Induced Type 2 Diabetes and Hypertension

Nimi Pullenkunnel Simon, Samira Sooreni Oliaie, Tro Thien Nguyen, Emmanuella Ezewudo, Sreelakshmi Menon, Raquibul Hasan

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.th173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Nimi Pullenkunnel Simon und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity, type 2 diabetes, and hypertension share a common pathophysiological component - endothelin-1 (ET-1) overproduction. Obesity associated adipose tissue dysfunction increases the systemic release of free fatty acids and proinflammatory cytokines. This creates an inflammatory hypoxic environment driving M1 macrophage infiltration, increasing TNF-α and IL-6 secretion. These cytokines upregulate endothelin-converting enzyme-1 (ECE-1), causing massive ET-1 overproduction, which triggers ROS and hyperinsulinemia to perpetuate a vicious cycle. We discovered that indole-3-acetic acid (IAA), a gut microbiota-derived metabolite, antagonizes endothelin receptors and inhibits ECE-1. This study investigates IAA's role in high-fat diet (HFD)-induced obesity, type 2 diabetes (OT2D), hypertension (HTN), and vascular dysfunction.

Methods

A diet-induced obesity model was developed by feeding Sprague Dawley rats a HFD for ten weeks. Recorded weekly blood pressure (BP), fasting blood glucose (FBG), body weight. Oral glucose tolerance tests (OGTT) and serum collections were performed twice. On week 5, rats received intraperitoneal streptozotocin (40mg/kg). From week 6, rats were treated via oral gavage with a vehicle, extended-release IAA (IAA-ER; 5 or 10mg/kg), aprocitentan (0.25mg/kg), or glibenclamide (5mg/kg). We also assessed lipid profiles, vascular function, tissue ET-1 levels, macrophage infiltration and polarization.

Results

IAA-ER attenuated hyperglycemia, glucose intolerance, and HOMA-IR in OT2D rats, suggesting improved insulin sensitivity. It improved lipid profiles by reducing bad and elevating good cholesterol. This was accompanied by the suppression of key inflammatory mediators (TNF-α, IL-6, leptin), providing an anti-inflammatory profile consistent with FBG and OGTT data. IAA-ER treatment also reduced BP elevations, improved vascular dysfunction, and decreased tissue ET-1 levels. It reduced macrophage infiltration and M1 polarization, driving a switch to an anti-inflammatory state.

Conclusions

The study suggests that IAA-ER provides systemic metabolic control, cardiovascular protection, and vascular integrity. Through ET system suppression and immunomodulation, IAA-ER delivers robust anti-inflammatory action and overall restoration of homeostasis.

Zitieren

APA

Simon, N. P., Oliaie, S. S., Nguyen, T. T., Ezewudo, E., Menon, S., & Hasan, R. (2026). Abstract TH173: Targeting the Endothelin System With a Gut Microbiota-Derived Metabolite in Obesity-Induced Type 2 Diabetes and Hypertension. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th173

Vancouver

Simon NP, Oliaie SS, Nguyen TT, Ezewudo E, Menon S, Hasan R. Abstract TH173: Targeting the Endothelin System With a Gut Microbiota-Derived Metabolite in Obesity-Induced Type 2 Diabetes and Hypertension. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th173

BibTeX
@article{Simon2026,
  author = {Simon, Nimi Pullenkunnel and Oliaie, Samira Sooreni and Nguyen, Tro Thien and Ezewudo, Emmanuella and Menon, Sreelakshmi and Hasan, Raquibul},
  title = {Abstract TH173: Targeting the Endothelin System With a Gut Microbiota-Derived Metabolite in Obesity-Induced Type 2 Diabetes and Hypertension},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.th173}
}
Kostenlos starten →